newsfilter
← Latest News
Business Wire·

ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences, Inc. (NASDAQ:PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced its Co-Chairmen of the Board, Robert Duggan and